Аторис® 10 мг таблетки, покрытые пленочной оболочкой

Country: Kyrgyzstan

Language: Russian

Source: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Active ingredient:

Аторвастатин

Available from:

КРКА д.д.,Ново место (КРКА д.д.,Ново место)

ATC code:

C10AA05

INN (International Name):

Atorvastatin

Dosage:

10 мг

Pharmaceutical form:

таблетки, покрытые пленочной оболочкой

Units in package:

№30

Prescription type:

по рецепту

Manufactured by:

КРКА д.д.,Ново место (Словения)

Therapeutic area:

Гиполипидемическое средство из группы статинов

Product summary:

ПЖВЛС: нет

Authorization date:

2017-06-22

Summary of Product characteristics

                                YTBEP)ITAAIO
rlepnufi
3aMecrrrreJrb
Ienepamnoro
ArrpexTopa
lenapranreHTa
JreKapcrBeHHoro
ooecneqeHr,rq
n
Mun
T,IHCTPYKWTfl,
IIO MEAIIIIIIHCKOMY
IIPI,IM
CPENCTBA
ATOP14C@
Topnonoe
HarrMeHoBaHr.re
Aropuc@
MexgyHapoAHoe
HerrareHToBauuoe
Ha[MeHoBaune
(MHH)
AropnacrarzH
JlercapcrneHHafl
Sopnra
rt
Ta6rerxv, rroKpbrrbre
nreno.{Hofi
o6ortoqxofi
Cocran
1 ra6rerra, noKpbrrar
nreHo-{uofi o6oro.rxofi coAepx{.rr:
,[eilcmeynu4ee
6eu4ecmso:
aropBacrar]IH
KIIJIrIII{I 10,36
ur
(srnunirJreHTHo
aropBacrarr.rHy
10,00
ur) AnrI aropBacrarl{H
Kanbllrrf,
20,72 ur
(srcnznareHTHo
aropBacrarrauy
20,00 r,rr).
BcnouoeameilbHbre
6eu4ecmsa: rroBLrAoH, lautpufl,
naypr4ncynrQar,
Kanbrlr4s
xap6onar,
qennrcno3a
MHKpoKpI4cTzuIJIVqecKag,
JraKTO3br
MoHotI,rApaT, KpOCKapMennO3a
IJATpVLA,
MAtIJI.lg,
creapaT.
O6onoqrca: Oua4paft
II
HP
85F28751
6enufi
(norununraronufi
cnrrpr,
rr{raHa
Ar.roKcr.rA,
MaKporon
3000, tanrr).
Ouucanue
Kpyuue,
cJIerKa
ABotKoBbInyKJIbIe
ra6nerxu,
[oKpbrrbre
nreno.rHofi
o6oroqxofi
6eloro
rlBera.
*
@apuarcoreparreBTrrqecKafl
rpyn[a
fvnolznuAeMzqecKl4e
[pelaparbl.
funoxorecrepuHeMr{rrecKr4e
lr rr4rrorpr{rnuqepr4AeMr,rqecKue
nperaparbr.
fMf
KoA-pe4yxra:rr
usru6r,rropbr.
Aropnacrarun.
Koa
ATX: C10AA05
@apvranolor[qecKr{e
cnoft
crna
@apmarcoduHcrl4uKa
Aropnacratzn
fIrnoJII4nLIAeMLIqecKoe
cpeAcrBo
n3
rpynnbr
crarr{HoB.
OcHosnrrll
MexaHI,I3Motrl
4eficreut
aropBacrarvrna
rBrrercs
ranru6uponaHue
aKTvrBHocrrr
3-rngporcn-3-
Merlrnfnyrapr.rn-KosHsrla
A
(fMf-KoA)-pegyrra":rr,
QepueHra,
Karanrl3r{pyrcuefo
npeBparrleHue
fMf-KoA
s MeBaJIoHoByIo
Klrcnory.
3ro
npeBprrTleuvre
flBJrfl.ercr
oAHr,rM
r{3
paHHvx
orarloB
B IIenI4
crrHTe3a
xonecrepr4Ha
B opraHlr3Me.
llo4aueuue
aropBacrarr.rHoM
cIrHTe3a
xonecrepl{Ha
rIpI,IBoAI4T
K rroBblruenHofi
peaKTr4BHocrr4
perlenropoB
nr4nonporer,IHoB
nasxofi
[JIorHocrI4
(IIIHD
B rIeqeHI{,
a raK)Ke
Bo BHeneqeHor{Hbrx
rKaHrx.
Srra
peqenropu
cBfl3blBalor
qacrullbl
JIIIHII
[I
yAantror
LIx
r{3 rrJra3Mbr
KpoBH,
qro
npl{BoAHT
K
cHr.rxeHr4ro
KoHrleHrparluu
xonecrepraua
(Xc)
JII*il
(Xo-JIIIHII)
n
uasue
KpoBlr.
rl;
EHHOTO
Anrucx
                                
                                Read the complete document
                                
                            

Documents in other languages